While it’s not as well-known as, say, leukemia or melanoma, multiple myeloma is the second most common blood cancer in adults, according to the Cancer Research Institute. “Multiple myeloma is a cancer ...
Multiple myeloma is a rare blood cancer of the plasma cells in bone marrow -- the soft, spongy interior of bone where all blood cells are produced. Plasma cells are a type of white blood cell that ...
Multiple myeloma is a type of blood cancer caused by a buildup of abnormal plasma cells in the bone marrow. As the abnormal plasma cells accumulate, they crowd out healthy cells and cause symptoms ...
Relapsed and refractory multiple myeloma can be difficult to manage, especially as patients progress through multiple lines of therapy and treatment options may become more limited. 1 Since the ...
Multiple myeloma is a blood cancer affecting plasma cells, causing abnormal antibody production and bone damage. Diagnosis involves blood tests, bone marrow biopsy, imaging, and genetic analysis to ...
Multiple Myeloma," Cleveland Clinic hematologist Sandra Mazzoni, DO, and host John Mangels continue their conversation on ...
Gagandeep Brar, MD, is a board-certified hematologist and medical oncologist. Her research interest is in gastrointestinal malignancies with a focus on immune and targeted therapies. Risk factors like ...
Bruce Springsteen and Patti Scialfa have been married since 1991. (Photo by Michael Buckner/Golden Globes 2024/Golden Globes 2024 via Getty Images) (Michael Buckner/Golden Globes 2024 via Getty Images ...
New therapies for multiple myeloma are dramatically improving prognosis and extending survival. Better disease control is prolonging remission and allowing patients to live without any sign of disease ...
When multiple myeloma returns after a period of remission, treatment plans often need to be adjusted because the cancer may have become resistant to previous medications. Doctors determine the most ...
“I walked in, and she was like, ‘You know why you’re here? ... I’m an orthopedic oncologist ... I do cancer,’ ” Eric Dillon ...